title: Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes.
abstract: Chromosomal abnormalities and gene mutations have become major determinants in the classification of kidney carcinomas. Most renal medullary carcinomas develop in patients with hereditary sickle cell disease, but sporadic cases unassociated with sickle cell disease have also been described, for which underlying genetic abnormality is unknown. We evaluated 3 patients with renal medullary carcinoma (1 patient with sickle cell disease and 2 patients without sickle cell disease) for germ line and somatic mutations in genes commonly involved in pathogenesis of renal carcinomas using denaturing high-performance liquid chromatography and direct sequencing. Chromosomal abnormalities were studied by the conventional cytogenetic and SNP arrays analysis. Expression of hypoxia-inducible factor 1α was examined using immunohistochemistry. Two new mutations in the gene for fumarate hydratase were identified in 1 case of medullary renal carcinoma without sickle cell disease: a germ line mutation in exon 6 (R233H) and an acquired (somatic) mutation in exon 8 (P374S). No fumarate hydratase mutations were identified in the other 2 patients. The second sporadic case of renal medullary carcinoma harbored double somatic mutations in von Hippel-Lindau gene, and renal medullary carcinoma in the patient with sickle cell disease showed von Hippel-Lindau gene promoter methylation (epigenetic silencing). No consistent pattern of chromosomal abnormalities was found between 2 cases tested. All 3 cases showed increased hypoxia-inducible factor 1α expression. Medullary renal carcinomas from patients with or without sickle cell disease show involvement of genes important in hypoxia-induced signaling pathways. Generalized cellular hypoxia (in sickle cell disease) or pseudohypoxia (in tumors with fumarate hydratase and von Hippel-Lindau mutations or epigenetic silencing) may act alone or in concert at the level of medullary tubular epithelium to promote development of this rare type of renal carcinoma, which could then be genetically reclassified as either fumarate hydratase-associated renal carcinomas or high-grade clear cell renal cell carcinomas.
authors: Department of Pathology, Creighton University School of Medicine, Omaha, NE 68131, USA. zorangatalica@creighton.edu
authors: Zoran
authors: Z
authors: Gatalica
authors: Stan L
authors: SL
authors: Lilleberg
authors: Federico A
authors: FA
authors: Monzon
authors: Manika Sapru
authors: MS
authors: Koul
authors: Julia A
authors: JA
authors: Bridge
authors: Joseph
authors: J
authors: Knezetic
authors: Ben
authors: B
authors: Legendre
authors: Poonam
authors: P
authors: Sharma
authors: Peter A
authors: PA
authors: McCue
mesh_terms: D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications; D018276:Carcinoma, Medullary / Q000145:classification* / Q000235:genetics / Q000473:pathology; D002292:Carcinoma, Renal Cell / Q000145:classification* / Q000235:genetics / Q000473:pathology; D002869:Chromosome Aberrations; D004252:DNA Mutational Analysis; D005091:Exons / Q000235:genetics; D017809:Fatal Outcome; D005649:Fumarate Hydratase / Q000235:genetics; D005838:Genotype; D018095:Germ-Line Mutation; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics; D007150:Immunohistochemistry; D059785:Karyotype; D007680:Kidney Neoplasms / Q000145:classification* / Q000235:genetics / Q000473:pathology; D008297:Male; D053842:Microsatellite Instability; D009154:Mutation; D010641:Phenotype; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics
chemical_list: C497442:HIF1A protein, human; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D005649:Fumarate Hydratase; C497446:VHL protein, human